• FPR2/ALX Modulation Restricts Autoimmune Astrocytopathy via

  2026-05-29

  This study demonstrates that stimulation of the formyl peptide receptor 2 (FPR2/ALX) attenuates neuroinflammation in a mouse model of autoimmune astrocytopathy by modulating microglia and natural killer (NK) cell responses. The findings highlight the therapeutic potential of targeting FPR2/ALX for diseases like neuromyelitis optica spectrum disorder (NMOSD), where conventional treatments often fail to halt disease progression.

• Protoporphyrin IX: Applied Workflows for Photodynamic Assays

  2026-05-29

  Protoporphyrin IX stands at the crossroads of heme metabolism and innovative photodynamic applications, enabling precise cancer diagnostics and experimental ferroptosis modulation. This guide delivers actionable workflows, troubleshooting strategies, and the latest translational insights, empowering researchers to harness APExBIO’s high-purity Protoporphyrin IX for reproducible, cutting-edge results.

• JNK-IN-7: Selective JNK Inhibitor for Apoptosis & MAPK Assay

  2026-05-28

  JNK-IN-7 empowers precise dissection of JNK signaling in cell models of inflammation and apoptosis. Its covalent, nanomolar inhibition and pathway selectivity make it a cornerstone for MAPK pathway research and immune modulation workflows.

• Spiroplasma eriocheiris Entry Requires Clathrin-Mediated End

  2026-05-28

  This study reveals that Spiroplasma eriocheiris invades Drosophila S2 cells primarily via clathrin-mediated endocytosis and macropinocytosis, not through caveola-dependent pathways. The findings clarify cellular mechanisms underlying S. eriocheiris infection and offer a framework for future host-pathogen research in invertebrate models.

• Low-Affinity Blockade of N-Type Ca Channels by v-Agatoxin-IV

  2026-05-27

  Sidach and Mintz revisited the pharmacological profile of v-Agatoxin-IVA, revealing its low-affinity blockade of neuronal N-type calcium channels in addition to established P- and Q-type selectivity. Their findings refine channel classification and inform experimental strategies targeting calcium signaling in neurons.

• LMO2–LDB1 Complex Drives AML Progression via Oncogenic Inter

  2026-05-27

  This study elucidates how the LMO2 transcription factor, through its interaction with the co-regulator LDB1, promotes acute myeloid leukemia (AML) cell proliferation and survival. By dissecting molecular mechanisms and identifying the LMO2/LDB1 complex as a potential therapeutic target, the research provides new directions for epigenetic and DNA fidelity studies in leukemia.

• MOG (35-55) Peptide: Optimizing Autoimmune Encephalomyelitis

  2026-05-26

  MOG (35-55) is the gold-standard myelin oligodendrocyte glycoprotein peptide for modeling autoimmune encephalomyelitis, enabling highly reproducible induction of neuroinflammation and demyelination akin to multiple sclerosis. This guide bridges cutting-edge mechanistic insights, proven protocols, and troubleshooting strategies to help researchers maximize the utility of APExBIO's MOG (35-55) Peptide in MS research and beyond.

• Cyclic Pifithrin-α Hydrobromide: Optimizing p53 Inhibition

  2026-05-26

  Cyclic Pifithrin-α hydrobromide empowers researchers to dissect the p53 signaling pathway, enabling precise apoptosis inhibition in cancer research and radioprotection workflows. This guide delivers actionable protocol enhancements, troubleshooting strategies, and cross-domain insights, translating the latest neuroinflammation findings into practical experimental design.

• BMN 673 (Talazoparib): Redefining PARP Inhibition in DNA Rep

  2026-05-25

  Explore how BMN 673 (Talazoparib) transforms DNA repair deficiency targeting through next-generation PARP1/2 inhibition. This article provides a mechanistic deep dive and practical guidance for advanced cancer research applications.

• Mitochondrial Calcium Signaling Suppresses Ferroptosis in Tu

  2026-05-25

  This study reveals a mechanistic link between mitochondrial calcium uptake via the MCU channel and repression of ferroptotic cell death in cancer cells. By regulating acetyl-CoA-dependent acetylation of GPX4, mitochondrial calcium signaling sustains GPX4 activity and tumor cell survival, offering novel insights for cancer metabolism research.

• CF10 and EdU Synergy Drives Telomere Attrition in CRC Cells

  2026-05-24

  The referenced study demonstrates that combining the fluoropyrimidine polymer CF10 with 5-ethynyl-2′-deoxyuridine (EdU) induces synergistic telomere attrition and mitotic catastrophe in colorectal cancer (CRC) cells. These findings highlight a novel approach for enhancing telomerase-targeted therapies and inform the rational design of future combinatorial cancer treatments.

• Substrate Specificity of GOB-38 in Elizabethkingia anophelis

  2026-05-23

  This study characterizes the biochemical properties and substrate spectrum of the novel metallo-β-lactamase GOB-38 from Elizabethkingia anophelis, revealing its broad activity against penicillins, cephalosporins, and carbapenems. The findings highlight the enzyme's unique active site composition and its potential to mediate multidrug resistance transfer during co-infection, with significant implications for antibiotic resistance surveillance.

• Prednisone: Mechanistic Leverage and Strategy for Translatio

  2026-05-22

  Explore how Prednisone, a synthetic corticosteroid, enables translational researchers to precisely model immunosuppression and apoptosis—bridging mechanistic insight, protocol optimization, and strategic guidance. This thought-leadership article synthesizes recent advances in metabolomics, cross-disciplinary workflow design, and rigorous preclinical benchmarking, offering actionable recommendations for maximizing experimental robustness and clinical relevance.

• GSK J4 HCl: JMJD3 Inhibition for Epigenetic Regulation Resea

  2026-05-22

  GSK J4 HCl stands out as a potent, cell-permeable JMJD3 inhibitor, enabling high-fidelity studies of histone demethylation and transcriptional regulation. Its robust performance in inflammation and tumor models empowers researchers to dissect chromatin-mediated mechanisms underlying immune function and disease.

• V5 Epitope Tag Peptide: Optimizing Protein Tagging Workflows

  2026-05-21

  The V5 Epitope Tag Peptide streamlines recombinant protein detection and purification across diverse experimental platforms, standing out for its compatibility with rapid antibody screening and advanced imaging. Explore protocol tips, troubleshooting, and the impact of fast-dissociating antibodies for next-generation protein tagging.

15648 records 1/1044 page Next 12345 下5页 Last page